Germany-based orthopaedic technology developer Mecuris, a spinout of Ludwig-Maximilian University (LMU) Hospital in Munich, has secured a “high six-figure sum” in seed financing from Bavarian state-owned investment firm Bayern Kapital.
High Tech Gründerfonds (HTGF), an early-stage investment group instituted by the German government, also invested in the round.
Founded in 2016, Mecuris is the developer of a platform that allows medical technicians to use data from patients’ three-dimensional scans to create orthopaedic aids and artificial limbs that are designed to fit each individual.
Mecuris makes the aids and limbs with the help of three-dimensional printers, and delivers them to their customers.
Wolf-Peter Werner, chief financial officer of Mecuris, said: “Our platform is a self-learning system that uses processes from the fields of artificial intelligence and medical image processing. The production of orthopaedic aids is thus conducted in a decentralised manner using [three-dimensional printing] in certified centres.”
Frank Hensel, investment manager at HTGF, added: “Doctors and orthopaedic technicians are able to use Mecuris’ technology without needing to have any previous technical know-how in [computer-aided design] or three-dimensional printing. Production time is reduced significantly thanks to the digital process chain.”
– Image of a prosthetic leg courtesy of Mecuris.
